Peter Garcia-Meza

President & Chief Executive Officer at C2 Therapeutics, Inc.

Peter Garcia-Meza

Peter Garcia-Meza

President & Chief Executive Officer at C2 Therapeutics, Inc.

Biography

Mr. Peter Garcia-Meza is President & Chief Executive Officer at C2 Therapeutics, Inc. He received his undergraduate degree from the University of Southern California and an MBA from Harvard University.

Overview
Career Highlights

C2 Therapeutics, Inc.

RelSci Relationships

25

Number of Boards

1

Relationships
RelSci Relationships are individuals Peter Garcia-Meza likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Operating Officer at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Former Managing Director at De Novo Ventures

Relationship likelihood: Strong

Founder at Alembic LLC

Relationship likelihood: Strong

Director at Rodo Medical, Inc.

Relationship likelihood: Strong

Treasurer/Vice President, Finance at Saint Vincent College

Relationship likelihood: Strong

Director at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Director of Clinical Research at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Director-Research & Development at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Vice President of Regulatory & Quality at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Vice President-Europe at C2 Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Peter Garcia-Meza
Potential Connections via
Relationship Science
You
Peter Garcia-Meza
President & Chief Executive Officer at C2 Therapeutics, Inc.
Education

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
President & Chief Executive Officer
2007 - Current

C2 Therapeutics, Inc. develops treatment for esophageal cancer. Its Coldplay CryoBalloon Focal Ablation System sets a new standard for simplicity in ablation of Barrett’s Esophagus. The company was founded by Peter Garcia-Meza in 2007 and is headquartered in Redwood City, CA.

Boards & Committees
Director
Tenure Unconfirmed

C2 Therapeutics, Inc. develops treatment for esophageal cancer. Its Coldplay CryoBalloon Focal Ablation System sets a new standard for simplicity in ablation of Barrett's Esophagus. The company was founded by Peter Garcia-Meza in 2007 and is headquartered in Redwood City, CA.

Transactions
Details Hidden

C2 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

C2 Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

C2 Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

C2 Therapeutics, Inc. develops treatment for esophageal cancer. Its Coldplay CryoBalloon Focal Ablation System sets a new standard for simplicity in ablation of Barrett’s Esophagus. The company was founded by Peter Garcia-Meza in 2007 and is headquartered in Redwood City, CA.

Other Affiliations

Peter Garcia-Meza is affiliated with C2 Therapeutics, Inc., C2 Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter Garcia-Meza. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter Garcia-Meza's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter Garcia-Meza.